Dividend compounder review

TAK

Takeda Pharmaceutical Co Ltd ADR · NYSE · US

Healthcare · Drug Manufacturers - Specialty & Generic

Chart Factor Intelligence Back to Screener
Score57.60/100
Confidence100.00/100
DecisionReject
RatingWeak Candidate
Scoring

Quality breakdown

Dividend Reliability 5.1 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 16.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 19.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 8.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 8.5 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years2
Dividend Yield4.17%
Payout Ratio80.0%
Dividend Cut 5YYes
Net Income$107.9B
Free Cash Flow$677.6B
FCF Covers DividendYes
Debt / Equity0.70
P/E43.0
Revenue Growth 5Y8.4%
Net Margin4.3%
ROE2.6%
Price vs Trend-4.4%
3Y Return6.8%
5Y Return0.4%
CurrencyUSD
Warnings

Review flags

Price currency USD differs from financial currency JPY.
Dividend history is short: 2 completed years.
Dividend cut or material annual decrease detected in the last five completed years.
Dividend diary

Activity record

TAK dividend review warning Warning · Warning

Dividend cut or material annual decrease detected in the last five completed years.

TAK dividend payment 0.339 USD Dividend Payment · Info

Recorded dividend payment for Takeda Pharmaceutical Co Ltd ADR.

Dividend increased 11.6% Dividend Increase · Positive

Payment changed from 0.292 to 0.326.

TAK dividend payment 0.326 USD Dividend Payment · Info

Recorded dividend payment for Takeda Pharmaceutical Co Ltd ADR.

TAK dividend payment 0.292 USD Dividend Payment · Info

Recorded dividend payment for Takeda Pharmaceutical Co Ltd ADR.